Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00089076 · BASELINE

Baseline characteristics

MDX-010 in Treating Patients With Recurrent or Refractory Lymphoma · Source last updated 2014-05-30

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      18
    units
    Participants
groups
  1. description
    Patients receive anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody (MDX-010) IV over 90 minutes on day 1. Treatment repeats every 28 days for a total of 4 courses in the absence of disease progression or unacceptable toxicity.
    id
    BG000
    title
    MDX-010
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          37
          upper Limit
          79
          value
          56
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          6
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          12
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          18
      title
      United States
    param Type
    NUMBER
    title
    Region of Enrollment
    unit Of Measure
    participants
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          9
      title
      Follicular grade 1 lymphoma
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          5
      title
      Follicular grade 2 lymphoma
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          3
      title
      Diffuse large B-cell lymphoma
    4. categories
      1. measurements
        1. group Id
          BG000
          value
          1
      title
      Mantle cell lymphoma
    param Type
    NUMBER
    title
    Disease Histology
    unit Of Measure
    participants
  5. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          1
          upper Limit
          4
          value
          2
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Number of prior treatments
    unit Of Measure
    Treatments
  6. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          12
      title
      3 mg/kg first dose, then 1 mg/kg monthly x 3 doses
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          6
      title
      3 mg/kg monthly x 4 doses
    param Type
    NUMBER
    title
    Dose Level
    unit Of Measure
    participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      18
    units
    Participants
groups
  1. description
    Patients receive anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody (MDX-010) IV over 90 minutes on day 1. Treatment repeats every 28 days for a total of 4 courses in the absence of disease progression or unacceptable toxicity.
    id
    BG000
    title
    MDX-010
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          37
          upper Limit
          79
          value
          56
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          6
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          12
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          18
      title
      United States
    param Type
    NUMBER
    title
    Region of Enrollment
    unit Of Measure
    participants
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          9
      title
      Follicular grade 1 lymphoma
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          5
      title
      Follicular grade 2 lymphoma
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          3
      title
      Diffuse large B-cell lymphoma
    4. categories
      1. measurements
        1. group Id
          BG000
          value
          1
      title
      Mantle cell lymphoma
    param Type
    NUMBER
    title
    Disease Histology
    unit Of Measure
    participants
  5. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          1
          upper Limit
          4
          value
          2
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Number of prior treatments
    unit Of Measure
    Treatments
  6. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          12
      title
      3 mg/kg first dose, then 1 mg/kg monthly x 3 doses
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          6
      title
      3 mg/kg monthly x 4 doses
    param Type
    NUMBER
    title
    Dose Level
    unit Of Measure
    participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice